可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]陈伟伟,高润霖,刘力生,等.2014中国心血管病报告[J].中国循环杂志,2014,30(7):617-622.
[2]Camm AJ,Kirchhof P,Lip GY,Schotten U,et al.Guidelines for the management of atrial fibrillation:the Task force for the management of atrial fibrillation of the european society of cardiology[J].Eur heart J,2010,31(19):2369-2429.
[3]Holmes DR Jr,Lakkireddy DR,Whitlock RP,et al.Left atrial appendage occlusion:opportunities and challenges[J].J Am Coll Cardiol,2014,63(4):291-298.
[4]中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会.华法林抗凝治疗中国专家共识[J].中华内科杂志,2013,52(1):76-82.
[5]Blackshear JL,Odell JA.Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J].Ann Thorac Surg,1996,61(2):755-759.
[6]中华医学会心电生理和起搏分会,中华医学会心血管病学分会,中国医师协会心律学专业委员会.左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议[J].中国心脏起搏与心电生理杂志,2014,28(6):471-486.
[7]Reddy VY,Sievert H,Halperin J,et al.Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation:A Randomized Clinical Trial[J].JAMA,2014,312(19):1988-1998.
[8]Reddy VY,Holmes D,Doshi SK,et al.Safety of percutaneous left atrial appendage closure results from the watchman left atrial appendage system for embolic protection in patients with AF(PROTECT AF)clinical trial and the continued access registry[J].Circulation,2011,123(4):417-424.
[9]Alli O,Doshi S,Kar S,et al.Quality of life assessment in the randomized PROTECT AF(Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation)trial of patients at risk for stroke with nonvalvular atrial fibrillation[J].J Am Coll Cardiol,2013,61(17):1790-1798.
[10]Reddy VY,M?bius-Winkler S,Miller MA,et al.Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation:the ASAP study(ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)[J].J Am Coll Cardiol,2013,61(25):2551-2556.
[11]Holmes DR Jr,Kar S,Price MJ,et al.Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy:the PREVAIL trial[J]J Am Coll Cardiol,2014,64(1):1-12.
[12]Bajaj NS,Parashar A,Agarwal S,et al.Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies[J]JAm Coll Cardiol Intv,2014,7(3):296-304.
[13]Holmes DR Jr,Doshi SK,Kar S,et al.Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation[J]J Am Coll Cardiol,2015,65(24):2614-2623.
[14]Zhou X,Zhang W,Lv W,et al.Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review[J]Int J Cardiol,2016,203:55-59.
[15]Briceno DF,Villablanca P,Cyrille N,et al.Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation[J].Circ Arrhythm Electrophysiol,2015,8(5):1057-1064.
[16]Romanov A,Pokushalov E,Artemenko S,et al.Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial[J].J Interv Card Electrophysiol,2015,44(1):9-16.
[17]John Camm A,Colombo A,Corbucci G,et al.Left atrial appendage closure:a new technique for clinical practice[J].Heart Rhythm,2014,11(3):514-521.